Jagsonpal Pharmaceuticals Limited has announced the completion of its acquisition of a 69.77% equity stake in Aequitas Healthcare Private Limited. This acquisition, part of a previously proposed 85% stake purchase, now makes Aequitas a subsidiary of Jagsonpal Pharmaceuticals Limited. The company has informed the stock exchanges, BSE Ltd and National Stock Exchange of India Ltd, about this development. The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The corporate office of Jagsonpal Pharmaceuticals Limited is located in Gurugram, Haryana, with its registered office in New Delhi.
